It's hard to imagine that one day we might all get some kind of normalcy back. We will head back to work, kids will go back to school, parks and beaches will reopen and there may even be events, concerts and parties. But the fight against COVID-19 will not be over quickly, it will be a slow race and we will have to remain safe and ensure we are sticking to a few key guidelines when the doors finally open.Original Article
You may also like
The Great RIF(T): One FDA Division’s Destruction and...
More on the Impact of the FDA RIFs: How Information...
Court Rejects Challenge to DEA ALJ Hearing Authority...
Déjà Vu: OPDP Again Targets Provider Branded Website...
ASCA 2024 Performance Update: Can ASCA Improve...
Enforcement Under the New FDA: HPM to Host a Q&A...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
